HomeCompareTPNI vs PFE

TPNI vs PFE: Dividend Comparison 2026

TPNI yields 2000000.00% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TPNI wins by $4.879226400974806e+39M in total portfolio value
10 years
TPNI
TPNI
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.879226400974806e+39M
Annual income
$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00
Full TPNI calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — TPNI vs PFE

📍 TPNI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTPNIPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TPNI + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TPNI pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TPNI
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, TPNI beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TPNI + PFE for your $10,000?

TPNI: 50%PFE: 50%
100% PFE50/50100% TPNI
Portfolio after 10yr
$2.439613200487403e+39M
Annual income
$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

TPNI
No analyst data
Altman Z
-185.7
Piotroski
5/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TPNI buys
0
PFE buys
0
No recent congressional trades found for TPNI or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTPNIPFE
Forward yield2000000.00%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$4.879226400974806e+39M$49.6K
Annual income after 10y$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$26,258.71
Total dividends collected$4.879195005460081e+39M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TPNI vs PFE ($10,000, DRIP)

YearTPNI PortfolioTPNI Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$200,010,700$200,000,000.00$9,153$693.39+$200.00MTPNI
2$3,738,731,768,458$3,738,517,757,009.35$8,593$849.25+$3738731.76MTPNI
3$65,315,062,866,930,490$65,311,062,423,938,240.00$8,336$1,066.78+$65315062866.92MTPNI
4$1,066,400,830,062,625,000,000$1,066,330,942,945,357,500,000.00$8,437$1,384.80+$1066400830062625.00MTPNI
5$16,272,182,796,453,826,000,000,000$16,271,041,747,565,660,000,000,000.00$9,013$1,875.40+$16272182796453826560.00MTPNI
6$232,054,240,113,661,900,000,000,000,000$232,036,828,878,069,680,000,000,000,000.00$10,306$2,680.72+$2.3205424011366188e+23MTPNI
7$3,092,799,066,104,688,500,000,000,000,000,000$3,092,550,768,067,767,400,000,000,000,000,000.00$12,820$4,101.38+$3.0927990661046884e+27MTPNI
8$38,524,105,697,352,694,000,000,000,000,000,000,000$38,520,796,402,351,967,000,000,000,000,000,000,000.00$17,673$6,826.70+$3.8524105697352695e+31MTPNI
9$448,468,826,014,798,700,000,000,000,000,000,000,000,000$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00$27,543$12,591.86+$4.484688260147987e+35MTPNI
10$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$49,560$26,258.71+$4.879226400974806e+39MTPNI

TPNI vs PFE: Complete Analysis 2026

TPNIStock

The Pulse Network, Inc. provides a cloud-based platform that focuses on content marketing and event solutions in the United States. It operates a cloud-based content marketing platform, which enables corporate marketers and event groups in their campaign efforts. The company's platform includes Content Marketing Platform that provides newsletters for outreach and engagement; Digital Publication Platform Creator, which develops digital publications; Video Webcast Production Platform that engages the audience with live video production, and enhances participation with live polls and chats; and Event Management Platform, which creates interactive customer experiences through registration and online engagement. Its platform also enhances registration counts through engagement and social sharing, and verification counts through connecting with the audience. In addition, the company offers ICTG platform, a marketing and follow up automation software; event management solution, an end-to-end tool for event groups worldwide; and HostMyLeads.com for lead management, as well as event technology, registration, lead generation, Web, and lead management program services for businesses, event organizers, and associations to engage with their community across channels, such as online, mobile, or face to face. Further, it provides Event Database Solutions comprising a multi-channel software-as-a-service platform for marketing support, registration, housing, management reporting, lead retrieval, online production, event Websites, and continuing education unit tracking, as well as services for marketing and event management. Additionally, the company offers content marketing tools that include syndication and distribution, social sharing, newsletter creation, analytics and reporting, prospect management, and other tools, as well as a content curation tool, which support the cloud-based platform. The Pulse Network, Inc. was founded in 1994 and is based in Norwood, Massachusetts.

Full TPNI Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this TPNI vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TPNI vs SCHDTPNI vs JEPITPNI vs OTPNI vs KOTPNI vs MAINTPNI vs JNJTPNI vs MRKTPNI vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.